Tiotropium - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/31082171/
Tiotropium maintenance therapy has well-established benefits for treating chronic obstructive lung disease. Mortality in chronic obstructive lung disease is often due to complications, including hyperinflation, decreased exercise tolerance, pulmonary infections,...
Conclusion/Relevance: This activity reviews the indications and contraindications, adverse effects, and monitoring of tiotropium. This activity also highlights the role of the interprofessional team in collaborating to manage patients who are using tiotropium.
Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35312525/
Article in English, Spanish] 1 Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Beitou District, Taipei City 11217, Taiwan, ROC; Center of Sleep Medicine,...
Conclusion: High baseline FENO can serve as an indicator of eosinophilic airway inflammation in COPD patients who may respond favorably to treatment with inhaled corticosteroids/long-acting β2-agonists.
The importance of having good quality indicators for care of patients with COPD: a look at hospital readmission rates - Israel Journal of Health Policy Research
Source : https://ijhpr.biomedcentral.com/articles/10.1186/s13584-022-00528-7
Background Readmission after hospitalization for acute COPD exacerbation (AE-COPD) has been proposed as a healthcare quality indicator (QI) in Israel. We studied patients hospitalized for AE-COPD, towards determining whether AE-COPD...
Conclusions: Readmitted COPD patients appear to be the sickest group of COPD patients with advanced disease and poor prognosis, and it may not be possible to prevent readmissions. This questions the utility of COPD readmissions as a healthcare quality indicator.
New insights into the optimal management of COPD: Extracts from CHEST 2021 annual meeting (October 17-20, 2021)
Source : https://www.tandfonline.com/doi/full/10.1080/17476348.2022.2056022
Abstract Abstract The mainstay of treatment for chronic obstructive pulmonary disease (COPD) is inhaled long-acting maintenance therapy, but discordance between real-world prescribing patterns and global treatment guidelines is increasingly being...
Conclusion/Relevance: Non-pharmacological, patient-related factors, such as inhalation technique and inspiratory flow, remain a key determinant of disease control in COPD, and over the past 18 months, new and unique challenges in the management of COPD have emerged as a result of the COVID-19 pandemic. This article summarizes a series of...